Filing Summary: Fresenius Medical Care AG & Co. KGaA
Business Context and Reporting Period
This Form 6-K filing covers the month of September 2010. The registrant, Fresenius Medical Care AG & Co. KGaA, is a German partnership limited by shares. The filing serves to disclose that company representatives conducted investor presentations in London, England, on September 1-2, 2010, during the Fresenius Medical Care Capital Markets Day Conference.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural notice regarding an investor event rather than a financial results report.
Material Changes
No material changes to financial performance or operations are detailed in this specific filing text. The document does not contain comparative data versus prior periods.
Guidance, Outlook, and Management Commentary
Management discussed the business and affairs of the Company during the Capital Markets Day Conference. The filing notes that a webcast replay and presentation materials are available on the company's website. No specific forward-looking guidance, risk factors, or contingencies are enumerated within the text of this Form 6-K.
Key Facts for Investor Verification
- The filing is a notice of an investor conference held on September 1-2, 2010, not a financial statement.
- Specific financial results and guidance must be verified by accessing the presentation materials or webcast replay at the URL provided in the filing (http://www.fmc-ag.com/2675.htm).
- The document is signed by Dr. Ben J. Lipps (CEO) and Michael Brosnan (CFO) on September 2, 2010.
- The information contained in this Form 6-K is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934.